Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000000650
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pre-Detection History of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Treatment Outcomes for Patients With Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2016English

Extensively Drug-Resistant Tuberculosis in South Africa

The Lancet
Medicine
2010English

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2013English

Drug Resistance Pattern in Pulmonary Tuberculosis Patients and Risk Factors Associated With Multi-Drug Resistant Tuberculosis

Journal of Tuberculosis Research
2017English

Multidrug and Extensively Drug-Resistant Tuberculosis

Infectious Disease Clinics of North America
Infectious DiseasesMicrobiology
2019English

Pharmacokinetics of Levofloxacin in Multidrug- And Extensively Drug-Resistant Tuberculosis Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Modelling Efficiency With Farm-Produced Inputs: Dairying in KwaZulu-Natal, South Africa

Agrekon
DevelopmentEconomicsCrop SciencePlanningAgronomyEconometricsGeography
2010English

Programmatic Management of Patients With Pre-Extensively Drug-Resistant Tuberculosis in Peru, 2011–2014

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy